Skip to Content

Xyzal Approval History

  • FDA approved: Yes (First approved May 25th, 2007)
  • Brand name: Xyzal
  • Generic name: levocetirizine dihydrochloride
  • Company: UCB, Inc. and sanofi-aventis
  • Treatment for: Allergic Rhinitis, Allergic Urticaria

Xyzal (levocetirizine) is an antihistamine for the relief of symptoms associated with allergic rhinitis and urticaria.

Development History and FDA Approval Process for Xyzal

Feb  1, 2017Approval Sanofi's Xyzal Allergy 24HR Approved for Over-the-Counter Use
Aug 25, 2009Approval FDA Approves Xyzal For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria
Feb 19, 2008Approval FDA Approves Xyzal (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
May 29, 2007Approval FDA Approves Xyzal (Levocetirizine Dihydrochloride) Tablets for the Relief of Seasonal and Year Round Allergies, and Chronic Hives
Jul 27, 2006UCB, Inc. Submits New Drug Application to FDA for Xyzal

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.